253 related articles for article (PubMed ID: 22337236)
1. C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8/A9 and procalcitonin.
Kim HA; Jeon JY; An JM; Koh BR; Suh CH
J Rheumatol; 2012 Apr; 39(4):728-34. PubMed ID: 22337236
[TBL] [Abstract][Full Text] [Related]
2. Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus.
Soyfoo MS; Roth J; Vogl T; Pochet R; Decaux G
J Rheumatol; 2009 Oct; 36(10):2190-4. PubMed ID: 19755614
[TBL] [Abstract][Full Text] [Related]
3. Serum procalcitonin and C-reactive protein for differentiating bacterial infection from disease activity in patients with systemic lupus erythematosus.
Yu J; Xu B; Huang Y; Zhao J; Wang S; Wang H; Yang N
Mod Rheumatol; 2014 May; 24(3):457-63. PubMed ID: 24252006
[TBL] [Abstract][Full Text] [Related]
4. Serum procalcitonin has negative predictive value for bacterial infection in active systemic lupus erythematosus.
Bador KM; Intan S; Hussin S; Gafor AH
Lupus; 2012 Oct; 21(11):1172-7. PubMed ID: 22652631
[TBL] [Abstract][Full Text] [Related]
5. The use of procalcitonin determinations in evaluation of systemic lupus erythematosus.
Quintana G; Medina YF; Rojas C; Fernandez A; Restrepo JF; Rondon F; Iglesias A
J Clin Rheumatol; 2008 Jun; 14(3):138-42. PubMed ID: 18525431
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracies of procalcitonin and C-reactive protein for bacterial infection in patients with systemic rheumatic diseases: a meta-analysis.
Song GG; Bae SC; Lee YH
Clin Exp Rheumatol; 2015; 33(2):166-73. PubMed ID: 25602442
[TBL] [Abstract][Full Text] [Related]
7. Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus.
Tydén H; Lood C; Gullstrand B; Jönsen A; Ivars F; Leanderson T; Bengtsson AA
Lupus; 2017 Feb; 26(2):139-149. PubMed ID: 27407135
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin and C-reactive protein as markers of infection in systemic lupus erythematosus: the controversy continues.
El-Serougy E; Zayed HS; Ibrahim NM; Maged LA
Lupus; 2019 Oct; 28(11):1329-1336. PubMed ID: 29779437
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
[TBL] [Abstract][Full Text] [Related]
10. Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.
Tydén H; Lood C; Gullstrand B; Jönsen A; Nived O; Sturfelt G; Truedsson L; Ivars F; Leanderson T; Bengtsson AA
Rheumatology (Oxford); 2013 Nov; 52(11):2048-55. PubMed ID: 23942785
[TBL] [Abstract][Full Text] [Related]
11. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.
Kim HA; An JM; Nam JY; Jeon JY; Suh CH
J Rheumatol; 2012 Jul; 39(7):1399-406. PubMed ID: 22660800
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome.
Simon L; Saint-Louis P; Amre DK; Lacroix J; Gauvin F
Pediatr Crit Care Med; 2008 Jul; 9(4):407-13. PubMed ID: 18496408
[TBL] [Abstract][Full Text] [Related]
13. Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus.
Lanoix JP; Bourgeois AM; Schmidt J; Desblache J; Salle V; Smail A; Mazière JC; Betsou F; Choukroun G; Duhaut P; Ducroix JP
Lupus; 2011 Feb; 20(2):125-30. PubMed ID: 20937623
[TBL] [Abstract][Full Text] [Related]
14. Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in Southeast Asia.
Lubell Y; Blacksell SD; Dunachie S; Tanganuchitcharnchai A; Althaus T; Watthanaworawit W; Paris DH; Mayxay M; Peto TJ; Dondorp AM; White NJ; Day NP; Nosten F; Newton PN; Turner P
BMC Infect Dis; 2015 Nov; 15():511. PubMed ID: 26558692
[TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin.
Sitter T; Schmidt M; Schneider S; Schiffl H
J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602
[TBL] [Abstract][Full Text] [Related]
16. Serum procalcitonin and C-reactive protein levels as diagnostic markers for distinguishing bacterial infections from lupus flares in systemic lupus erythematosus: A systematic review and meta‑analysis.
Chen Y; Shen J; Yang H; Xu S; Ma Y; Pan F
Int Immunopharmacol; 2021 Dec; 101(Pt B):108304. PubMed ID: 34731783
[TBL] [Abstract][Full Text] [Related]
17. Measuring serum levels of high-mobility group box 1 by enzyme-linked immunosorbent assay does not identify bacterial infections in patients with systemic lupus erythematosus.
Tang KT; Hsieh TY; Chen YM; Hsieh CW; Chen YH; Chen DY
Lupus; 2014 Aug; 23(9):926-34. PubMed ID: 24704776
[TBL] [Abstract][Full Text] [Related]
18. Levels of serum procalcitonin and C-reactive protein for evaluating pulmonary bacterial infection in patients with lupus erythematosus.
Gao J; Zhang L; Zhang X; Zhao SL; Liu SY; Xing LH
J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):653-658. PubMed ID: 27752903
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic values of C-reactive protein and procalcitonin in identifying systemic lupus erythematosus infection and disease activity.
Wang J; Niu R; Jiang L; Wang Y; Shao X; Wu M; Ma Y
Medicine (Baltimore); 2019 Aug; 98(33):e16798. PubMed ID: 31415387
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum presepsin, procalcitonin, copeptin, and high-sensitivity C-reactive protein for differentiating bacterial infection from disease activity in Egyptian patients with systemic lupus erythematosus.
AlJarhi UM; Sadek KM; Darwish EM; Elmessiery RM; Salem K; Khalil SA; Seif El Nasr SM; Kamel MF; Hesham D; Fayed A
Clin Rheumatol; 2021 May; 40(5):1861-1869. PubMed ID: 33111183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
